The press release heavily relies on forward-looking statements, indicating a potential lack of concrete results and leaving room for uncertainty about the company's future performance. There is an ...

Open Biosystems, Inc. has announced that the Peter MacCullum Cancer Centre has joined its Open Access RNAi Program. Through this program, the Peter MacCullum Cancer Centre has purchased Open ...

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing ...